Synapse - Works

Results (12615)

Genomic landscapes in elderly AML

Meeting Abstract

Rapaport, F.; Baslan, T.; Wang, L.; Sheridan, C.; Lee, T.; Hricik, T.; de Massy, M. R.; Telis, L.; Neelamraju, Y.; Medina, J.; more...
Blood (2017)

Fulltext@MSK | Save

Population-scale identification of clonal hematopoiesis derived mutations in solid tumor mutation profiling

Meeting Abstract

Ptashkin, R.; Coombs, C. C.; Hyman, D. M.; Solit, D.; Baselga, J.; Arcila, M. E.; Ladanyi, M.; Levine, R. L.; Berger, M. F.; Zehir, A.
Blood (2017)

Fulltext@MSK | Save

Use of next generation sequencing and single nucleotide polymorphism (SNP) fingerprinting to assess post transplant engraftment status

Meeting Abstract

Mohanty, A. S.; Gomez-Gelvez, J. C.; Petrova-Drus, K.; Zaidinski, M.; Wang, W.; Yao, J. J.; Ho, C.; Zehir, A.; Arcila, M. E.
Blood (2017)

Fulltext@MSK | Save

A phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory B-and T-cell lymphomas

Meeting Abstract

Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M. A.; Lynch, P.; Scheuerman, M.; Minnal, V.; Galasso, N.; Kumar, A.; Gerecitano, J.; Zelenetz, A. D.; more...
Blood (2017)

Fulltext@MSK | Save

MRD response-driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone

Meeting Abstract

Korde, N.; Mailankody, S.; Smith, E. L.; Lendvai, N.; Hassoun, H.; Lesokhin, A.; Hultcrantz, M.; Chung, D. J.; Shah, G. L.; Koehne, G.; more...
Blood (2017)

Fulltext@MSK | Save

B-cell maturation antigen is exclusively expressed in a wide range of B-cell and plasma cell neoplasm and in a potential therapeutic target for BCMA directed therapies

Meeting Abstract

Khattar, P.; Pichardo, J.; Jungbluth, A.; Gao, Q.; Smith, E. L.; Roshal, M.; Dogan, A.
Blood (2017)

Fulltext@MSK | Save

Early results from a biomarker-directed phase 2 trial of SY-1425 in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) demonstrate DHRS3 induction and myeloid differentiation following Sy-1425 treatment

Meeting Abstract

Jurcic, J. G.; Raza, A.; Vlad, G.; Stein, E. M.; Roshal, M.; Bixby, D. L.; Boyer, D. F.; Vigil, C. E.; Syrbu, S.; Sekeres, M. A.; more...
Blood (2017)

Fulltext@MSK | Save

Genomic characteristics clinical phenotype and disease course of TP53 mutated diffuse large B cell lymphoma at diagnosis and relapse

Meeting Abstract

Joffe, E.; Batlevi, C. L.; Intlekofer, A. M.; Zelenetz, A. D.; Moskowitz, C. H.; Palomba, M. L.; Noy, A.; Straus, D. J.; Portlock, C. S.; Gerecitano, J.; more...
Blood (2017)

Fulltext@MSK | Save

Allogeneic hematopoietic stem cell transplantation for multiple myeloma benefits patients with persistent disease and results in a high rate of residual disease clearance

Meeting Abstract

Getta, B.; Roshal, M.; Koehne, G.
Blood (2017)

Fulltext@MSK | Save

Molecular profiling in extramedullary acute myeloid leukemia reveals distinct subgroups defined by mutations in KIT and RUNX1

Meeting Abstract

Goldberg, A. D.; Farnoud, N.; Goldberger, C.; Patel, M.; Famulare, C.; Medina, J.; Rampal, R. K.; Levine, R. L.; Berman, E.; Zhang, Y.; more...
Blood (2017)

Fulltext@MSK | Save